TRAIL/TNFSF10 Antibody (75411) [DyLight 405]
Novus Biologicals, part of Bio-Techne | Catalog # FAB375E

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Neutralization
Label
DyLight 405 (Excitation = 400 nm, Emission = 420 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 75411
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human TRAIL/TNFSF10
Thr95-Gly281
Accession # P50591
Thr95-Gly281
Accession # P50591
Specificity
Detects human TRAIL/TNFSF10 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for TRAIL/TNFSF10 Antibody (75411) [DyLight 405]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Neutralization
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from ascites
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: TRAIL/TNFSF10
Long Name
TNF-related Apoptosis-inducing Ligand
Alternate Names
CD253, TNFSF10
Gene Symbol
TNFSF10
Additional TRAIL/TNFSF10 Products
Product Documents for TRAIL/TNFSF10 Antibody (75411) [DyLight 405]
Product Specific Notices for TRAIL/TNFSF10 Antibody (75411) [DyLight 405]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...